Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Annabelle Dietrich"'
Publikováno v:
Pharmaceuticals, Vol 17, Iss 9, p 1217 (2024)
Lipid nanoparticles (LNPs) and their versatile nucleic acid payloads bear great potential as delivery systems. Despite their complex lipid composition, their quality is primarily judged by particle characteristics and nucleic acid encapsulation. In t
Externí odkaz:
https://doaj.org/article/be3cc5bab4a144b7b68537a70d5f0cdc
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 12 (2024)
Virus-like particles (VLPs) are a promising class of biopharmaceuticals for vaccines and targeted delivery. Starting from clarified lysate, VLPs are typically captured by selective precipitation. While VLP precipitation is induced by step-wise or con
Externí odkaz:
https://doaj.org/article/781a4b0952a94375b029e37c6b58fcfd
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 8 (2020)
Virus-like particles (VLPs) are emerging nanoscale protein assemblies applied as prophylactic vaccines and in development as therapeutic vaccines or cargo delivery systems. Downstream processing (DSP) of VLPs comes both with challenges and opportunit
Externí odkaz:
https://doaj.org/article/23ae79eef75a439ca6cc4b934105a5cb
Publikováno v:
Biotechnology and Bioengineering. 118:3926-3940
Virus-like particles (VLPs) are particulate structures, which are applied as vaccines or delivery vehicles. VLPs assemble from subunits, named capsomeres, composed of recombinantly expressed viral structural proteins. During downstream processing, in
Publikováno v:
Biotechnology and Bioengineering, 119 (6), 1522-1538
Virus-like particles (VLPs) are an emerging biopharmaceutical modality with great potential as a platform technology. VLPs can be applied as gene therapy vectors and prophylactic or therapeutic vaccines. For non-enveloped VLPs, recombinant production